Variant report
Variant | esv3355423 |
---|---|
Chromosome Location | chr1:153401528-153405726 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:137)
- CpG islands (count:0)
- Chromatin interactive region (count:11)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr1:153405377-153406198 | K562 | blood: | n/a | n/a |
2 | ATF1 | chr1:153405647-153406276 | K562 | blood: | n/a | n/a |
3 | BHLHE40 | chr1:153403613-153403905 | K562 | blood: | n/a | n/a |
4 | BHLHE40 | chr1:153405547-153406281 | K562 | blood: | n/a | n/a |
5 | CBX3 | chr1:153405394-153406110 | K562 | blood: | n/a | n/a |
6 | CCNT2 | chr1:153405498-153406228 | K562 | blood: | n/a | n/a |
7 | CEBPD | chr1:153405458-153406339 | K562 | blood: | n/a | n/a |
8 | CEBPD | chr1:153405561-153406296 | K562 | blood: | n/a | n/a |
9 | CTCF | chr1:153403727-153403751 | GM12891 | blood: | n/a | n/a |
10 | CTCF | chr1:153401426-153401546 | MCF-7 | breast: | n/a | chr1:153401483-153401496 |
11 | CTCF | chr1:153401419-153401548 | K562 | blood: | n/a | chr1:153401483-153401496 |
12 | CTCF | chr1:153401427-153401530 | MCF-7 | breast: | n/a | chr1:153401483-153401496 |
13 | CTCF | chr1:153401380-153401530 | GM12872 | blood: | n/a | chr1:153401483-153401496 |
14 | CTCF | chr1:153401438-153401553 | HepG2 | liver: | n/a | chr1:153401483-153401496 |
15 | CTCF | chr1:153401480-153401630 | NHDF-neo | bronchial: | n/a | chr1:153401483-153401496 |
16 | CTCF | chr1:153403688-153403774 | GM19239 | blood: | n/a | n/a |
17 | CTCF | chr1:153401380-153401530 | AG04450 | lung: | n/a | chr1:153401483-153401496 |
18 | CTCF | chr1:153401400-153401550 | GM12873 | blood: | n/a | chr1:153401483-153401496 |
19 | CTCF | chr1:153401310-153401684 | H1-hESC | embryonic stem cell: | n/a | chr1:153401483-153401496 |
20 | CTCF | chr1:153401400-153401550 | WERI-Rb-1 | eye: | n/a | chr1:153401483-153401496 |
21 | CTCF | chr1:153401380-153401530 | HRE | kidney: | n/a | chr1:153401483-153401496 |
22 | CTCF | chr1:153401420-153401570 | GM12873 | blood: | n/a | chr1:153401483-153401496 |
23 | CTCF | chr1:153401380-153401530 | HEK293 | kidney: | n/a | chr1:153401483-153401496 |
24 | CTCF | chr1:153401460-153401610 | HMF | breast: | n/a | chr1:153401483-153401496 |
25 | CTCF | chr1:153401420-153401570 | BE2_C | brain: | n/a | chr1:153401483-153401496 |
26 | CTCF | chr1:153401400-153401550 | BE2_C | brain: | n/a | chr1:153401483-153401496 |
27 | CTCF | chr1:153401420-153401570 | WERI-Rb-1 | eye: | n/a | chr1:153401483-153401496 |
28 | CTCF | chr1:153401440-153401590 | SK-N-SH_RA | brain: | n/a | chr1:153401483-153401496 |
29 | CTCF | chr1:153401380-153401530 | HRPEpiC | eye: | n/a | chr1:153401483-153401496 |
30 | CTCF | chr1:153401411-153401551 | MCF-7 | breast: | n/a | chr1:153401483-153401496 |
31 | CTCF | chr1:153401500-153401650 | NHEK | skin: | n/a | n/a |
32 | CTCF | chr1:153401420-153401570 | GM12871 | blood: | n/a | chr1:153401483-153401496 |
33 | CTCF | chr1:153401380-153401530 | HCT-116 | colon: | n/a | chr1:153401483-153401496 |
34 | CTCF | chr1:153401400-153401550 | Hela-S3 | cervix: | n/a | chr1:153401483-153401496 |
35 | CTCF | chr1:153403753-153403774 | MCF-7 | breast: | n/a | n/a |
36 | CTCF | chr1:153401305-153401611 | H1-hESC | embryonic stem cell: | n/a | chr1:153401483-153401496 |
37 | CTCF | chr1:153401380-153401530 | HPAF | blood vessel: | n/a | chr1:153401483-153401496 |
38 | CTCF | chr1:153403560-153403710 | WERI-Rb-1 | eye: | n/a | n/a |
39 | CTCF | chr1:153401580-153401730 | HCM | heart: | n/a | n/a |
40 | CTCF | chr1:153401600-153401750 | A549 | lung: | n/a | n/a |
41 | CTCF | chr1:153402120-153402270 | HEEpiC | esophagus: | n/a | n/a |
42 | CTCF | chr1:153401380-153401530 | Caco-2 | colon: | n/a | chr1:153401483-153401496 |
43 | CTCF | chr1:153401439-153401539 | MCF-7 | breast: | n/a | chr1:153401483-153401496 |
44 | CTCF | chr1:153403605-153403619 | GM19239 | blood: | n/a | n/a |
45 | CTCF | chr1:153401460-153401610 | HepG2 | liver: | n/a | chr1:153401483-153401496 |
46 | CTCF | chr1:153401430-153401561 | Hela-S3 | cervix: | n/a | chr1:153401483-153401496 |
47 | CTCF | chr1:153401440-153401590 | HMEC | breast: | n/a | chr1:153401483-153401496 |
48 | CTCF | chr1:153401380-153401686 | K562 | blood: | n/a | chr1:153401483-153401496 |
49 | CTCF | chr1:153401600-153401750 | BE2_C | brain: | n/a | n/a |
50 | CTCF | chr1:153401388-153401596 | H1-hESC | embryonic stem cell: | n/a | chr1:153401483-153401496 |
No data |
(count:11 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:153333614..153335314-chr1:153401856..153404570,2 | MCF-7 | breast: | |
2 | chr1:153404704..153408499-chr1:153408737..153412962,4 | K562 | blood: | |
3 | chr1:153401556..153403433-chr1:153405617..153407706,2 | K562 | blood: | |
4 | chr1:153335876..153338098-chr1:153401901..153404705,2 | MCF-7 | breast: | |
5 | chr1:153333002..153335698-chr1:153404883..153407063,2 | MCF-7 | breast: | |
6 | chr1:153401442..153403093-chr1:153408398..153410070,2 | MCF-7 | breast: | |
7 | chr1:153402848..153404645-chr1:153405080..153406621,2 | MCF-7 | breast: | |
8 | chr1:153365407..153367710-chr1:153401211..153403404,2 | MCF-7 | breast: | |
9 | chr1:153401556..153403433-chr1:153405617..153407706,2 | K562 | blood: | |
10 | chr1:153397872..153400976-chr1:153401654..153403402,3 | MCF-7 | breast: | |
11 | chr1:153402848..153404645-chr1:153405080..153406621,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000203781 | TF binding region |
ENSG00000203781 | chromatin interactions |
ENSG00000197364 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs540174256 | chr1:153401531-153401532 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs36026521 | chr1:153401535-153401536 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs553623715 | chr1:153401540-153401541 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs567004530 | chr1:153401565-153401566 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs112538681 | chr1:153401572-153401573 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs3014824 | chr1:153401588-153401589 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
7 | rs555598522 | chr1:153401610-153401611 | Weak transcription Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs3006423 | chr1:153401664-153401665 | Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs370693008 | chr1:153401666-153401667 | Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs553491376 | chr1:153401706-153401707 | Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs576613101 | chr1:153401707-153401708 | Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs146671078 | chr1:153401715-153401716 | Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs149812724 | chr1:153401774-153401775 | Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs184317455 | chr1:153401798-153401799 | Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs557763838 | chr1:153401826-153401827 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs113945641 | chr1:153401843-153401844 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs540209532 | chr1:153401935-153401936 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs145811830 | chr1:153401948-153401949 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs573815418 | chr1:153401971-153401972 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs201142481 | chr1:153401994-153401995 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs141795199 | chr1:153402015-153402016 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs562518293 | chr1:153402039-153402040 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs192924619 | chr1:153402055-153402056 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs551489422 | chr1:153402059-153402060 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs184696791 | chr1:153402060-153402061 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs533666419 | chr1:153402065-153402066 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs539277341 | chr1:153402113-153402114 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs570413776 | chr1:153402155-153402156 | Weak transcription Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs147110499 | chr1:153402188-153402189 | Weak transcription Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs549820204 | chr1:153402209-153402210 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs567831655 | chr1:153402257-153402258 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs535232137 | chr1:153402317-153402318 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs553552691 | chr1:153402323-153402324 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs138574170 | chr1:153402340-153402341 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs539708691 | chr1:153402345-153402346 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs189672938 | chr1:153402412-153402413 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs73020416 | chr1:153402463-153402464 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs562126207 | chr1:153402500-153402501 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs375104297 | chr1:153402513-153402514 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs556003816 | chr1:153402526-153402527 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs180750937 | chr1:153402586-153402587 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs541587945 | chr1:153402610-153402611 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs78948762 | chr1:153402619-153402620 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs533602218 | chr1:153402671-153402672 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs552030608 | chr1:153402672-153402673 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs576266781 | chr1:153402673-153402674 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs150574056 | chr1:153402686-153402687 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs563850462 | chr1:153402751-153402752 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs531302986 | chr1:153402752-153402753 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs143037309 | chr1:153402768-153402769 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20409316 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Lung cancer | 18438408 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Systemic lupus erythematosus | 21956041 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 17899364 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Osteosarcoma | 17242211 | CNVD |
Ovarian cancer | 17242211 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Schizophrenia | 18990708 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Plasma-cell dyscrasia | 16705089 | CNVD |
Myeloma | 17024118 | CNVD |
Cancer | 17060936 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Type 2 diabetes | 19141583 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Breast cancer | 21509527 | CNVD |
Bladder cancer | 21909424 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Gastrointestinal cancer | 16790693 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Breast cancer | 21611746 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:153401400-153403400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr1:153401600-153402200 | Bivalent Enhancer | Foreskin Keratinocyte Primary Cells skin02 | Skin |
3 | chr1:153401800-153402800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr1:153401800-153403000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr1:153402000-153402600 | Enhancers | NHEK | skin |
6 | chr1:153402000-153403800 | Enhancers | Esophagus | oesophagus |
7 | chr1:153402200-153403000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
8 | chr1:153402600-153403600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
9 | chr1:153403200-153407200 | Enhancers | K562 | blood |
10 | chr1:153403400-153403600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
11 | chr1:153403400-153404000 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
12 | chr1:153403600-153403800 | Flanking Active TSS | H1 Derived Mesenchymal Stem Cells | ES cell derived |
13 | chr1:153403600-153404000 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
14 | chr1:153404000-153404600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
15 | chr1:153404000-153413800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
16 | chr1:153404600-153406000 | Enhancers | Placenta | Placenta |
17 | chr1:153405200-153406800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |